유럽 ​​약물 발견을 위한 의약 화학 시장 – 2029년까지의 산업 동향 및 예측

TOC 요청 TOC 요청 분석가에게 문의 분석가에게 문의 지금 구매 지금 구매 구매하기 전에 문의 구매하기 전에 문의 무료 샘플 보고서 무료 샘플 보고서

유럽 ​​약물 발견을 위한 의약 화학 시장 – 2029년까지의 산업 동향 및 예측

  • Pharmaceutical
  • Published Report
  • Feb 2022
  • Europe
  • 350 Pages
  • 테이블 수: 92
  • 그림 수: 39

>유럽 ​​약물 발견을 위한 의약 화학 시장, 프로세스별( 대상 선택, 대상 검증, Hit-To-Lead 식별, 리드 최적화 및 후보 검증), 설계(단편 기반 변형, 구조 기반 약물 설계, 다양성 지향 합성, 화학 유전체학, 천연물 및 기타), 약물 유형(소분자 및 생물학), 치료 영역( 종양학 , 신경학, 감염 및 면역 체계 질환, 심혈관 질환, 소화계 질환 및 기타), 최종 사용자(계약 연구 기관, 제약 및 생명 공학 회사, 학술 및 연구 기관 및 기타), 국가(독일, 영국, 프랑스, ​​이탈리아, 스페인, 네덜란드, 러시아, 스위스, 벨기에, 터키, 오스트리아, 노르웨이, 헝가리, 리투아니아, 아일랜드, 폴란드, 유럽의 나머지 지역) 산업 동향 및 2029년까지의 예측

유럽 ​​약물 발견 시장을 위한 의약 화학

시장 분석 및 통찰력 : 약물 발견을 위한 유럽 의약 화학 시장

유럽 ​​약물 발견을 위한 의약 화학 시장은 2022년부터 2029년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2022년부터 2029년까지의 예측 기간 동안 13.7%의 CAGR로 성장하고 있으며 2029년까지 3,890.66백만 달러에 도달할 것으로 예상한다고 분석합니다. 새로운 약물 분자의 발견 및 개발을 위한 연구 개발 투자 증가와 만성 질환의 증가는 예측 기간 동안 시장 수요를 촉진한 주요 요인입니다.

약물 발견을 위한 의약 화학은 안전하고 효과적인 약물에 대한 수요 증가와 같은 특징을 포함하며, 이는 제조업체가 시장에 새로운 제품을 출시하는 데 영향을 미쳐 수요를 증가시키고 새로운 약물 분자의 발견 및 개발을 위한 연구 개발 투자가 증가하여 시장 성장으로 이어집니다. 현재 다양한 연구가 진행 중이며, 이는 약물 발견을 위한 의약 화학 시장에서 다양한 다른 기회를 제공할 것으로 예상됩니다. 그러나 제형 약물의 비용 상승과 숙련된 기술 전문가의 부족으로 인해 예측 기간 동안 시장 성장이 제한될 것으로 예상됩니다.

약물 발견을 위한 의약 화학 시장 보고서는 시장 점유율, 새로운 개발 및 제품 파이프라인 분석, 국내 및 지역 시장 참여자의 영향, 새로운 수익 주머니, 시장 규정의 변화, 제품 승인, 전략적 의사 결정, 제품 출시, 지리적 확장 및 시장의 기술 혁신 측면에서의 분석 기회에 대한 세부 정보를 제공합니다. 분석 및 시장 시나리오를 이해하려면 분석가 브리핑을 위해 저희에게 연락하세요. 저희 팀은 원하는 목표를 달성하기 위한 수익 영향 솔루션을 만드는 데 도움을 드릴 것입니다.

유럽 ​​약물 발견 시장을 위한 의약 화학

약물 발견을 위한 의약 화학 시장 범위 및 시장 규모

Medicinal chemistry for drug discovery market is segmented on the based on the basis of process, design, drug type, therapeutic area, end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of process, the Europe medicinal chemistry for drug discovery market is segmented into target selection, target validation, hit-to-lead identification, lead optimization, and candidate validation. In 2022, target selection segment is expected to dominate the market owing to the fact that is the first process performed for medicinal chemistry for drug discovery and approximately every drug molecule passes through this process before entering the next process.
  • On the basis of design, the Europe medicinal chemistry for drug discovery market is segmented into fragment-based variation, structure-based drug design, diversity oriented synthesis, chemogenomics, natural products and others. In 2022, the fragment based variation segment is expected to dominate the market as this design provides with highly accurate results and majorly used for discovery of small molecule drugs.
  • On the basis of drug type, the Europe medicinal chemistry for drug discovery market is segmented into small molecules and biologics. In 2022, small molecules segment is expected to dominate the market as most of the drug going under drug discovery are small molecules as compared to that of the biologic drug molecules.
  • On the basis of therapeutic area, the Europe medicinal chemistry for drug discovery market is segmented into oncology, infectious and immune system disease, neurology, cardiovascular disease, digestive system disease and others. In 2022, oncology segment is expected to dominate the market due to increasing prevalence of different cancer types and rising demand of advanced, safe and effective therapeutic molecules.
  • On the basis of end user, the Europe medicinal chemistry for drug discovery market is segmented into contract research organization, academic and research institutes, pharmaceutical & biotechnology companies and others. In 2022, contract research organization is expected to dominate in the market as these organizations are highly focused on drug discovery and most of the pharmaceuticals, biotechnology companies among others work in collaboration with contract research organization for accelerated drug discovery.

유럽 ​​약물 발견 시장을 위한 의약 화학

Medicinal Chemistry for Drug Discovery Market Country Level Analysis

The medicinal chemistry for drug discovery market is analyzed and market size information is provided on the basis of process, design, drug type, therapeutic area and end user.

The countries covered in the medicinal chemistry for drug discovery market report are the Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Belgium, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, rest of Europe.

Germany is leading the growth of the Europe medicinal chemistry for drug discovery market and target selection segment is dominating in this country due to increase in collaboration among researchers and pharmaceutical industries. France is expected to grow due to the increasing research facility institutes in France and growing pharmaceutical expenditure. U.K. is expected to grow due to growing technological advancement for drug development.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Rise in healthcare expenditure and rising funding for research and development are boosting the market growth of medicinal chemistry for drug discovery

Medicinal chemistry for drug discovery market also provides you with detailed market analysis for every country growth in medicinal chemistry for drug discovery industry with medicinal chemistry for drug discovery sales, impact of advancement in the medicinal chemistry for drug discovery technology and changes in regulatory scenarios with their support for the medicinal chemistry for drug discovery market. The data is available for historic period 2011 to 2020.

Competitive Landscape and Medicinal Chemistry for Drug Discovery Market Share Analysis

Medicinal chemistry for drug discovery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to medicinal chemistry for drug discovery market.

약물 발견 시장을 위한 의약 화학 분야에서 활동하는 주요 기업으로는 Eurofins Scientific, Covance Inc.(현재 LabCorp Group의 일부), WuXi Apptec, Charles River, Thermo Fisher Scientific, Inc., Pfizer, Inc., Certara, USA, Malvern Panalytical Ltd(모회사 Spectris PLC), Genscript Biotech Corporation, Aurigene Pharmaceutical Services Ltd.(Dr. Reddy's Laboratories Ltd.의 자회사), Selvita 등이 있습니다.

다양한 시장 참여자들이 약물 발견을 위한 최신 의약 화학 기술을 제공하고 있으며, 이는 약물 발견을 위한 의약 화학 시장을 가속화하고 있습니다.

예를 들어,

  • 2021년 5월, Charles River는 미국 최고의 유전자 치료 계약 개발 및 제조 기관(CDMO)인 Vigene Biosciences, Inc.를 인수하기 위한 확정 계약을 체결했습니다. 이 회사는 약물 발견 프로세스를 개선하기 위한 바이러스 벡터 기반 유전자 전달 솔루션을 제공하는 데 참여하고 있습니다. 이 이니셔티브는 약물 발견 시장을 위한 의약 화학 분야에서 회사의 입지를 강화했습니다.
  • 2020년 8월, Malvern 분석은 Amplify Analytics를 출시하여 제약 회사가 생물학적 이용 가능성을 충족하는 약물 후보를 신속하게 식별하고 약물 개발 프로세스를 가속화할 수 있도록 했습니다. 이 이니셔티브는 약물 발견 시장을 위한 의약 화학 분야에서 회사의 성장을 촉진했습니다.

협력, 제품 출시, 사업 확장, 수상 및 인정, 합작 투자 및 시장 참여자의 기타 전략은 약물 발견을 위한 의약 화학 분야에서 회사 시장을 강화하고 있으며, 이는 조직이 기관지확장증에 대한 제공 사항을 개선하는 데에도 도움이 됩니다.


SKU-

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

  • 대화형 데이터 분석 대시보드
  • 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
  • 사용자 정의 및 질의를 위한 리서치 분석가 액세스
  • 대화형 대시보드를 통한 경쟁자 분석
  • 최신 뉴스, 업데이트 및 추세 분석
  • 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
데모 요청

목차

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 MARKET END USER COVERAGE GRID

2.8 PROCESS LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 POTERS FIVE FORCES

5 EUROPE MEDICINAL CHEMISTRY IN DRUG DISCOVERY MARKET: REGULATIONS

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASE IN R&D FOR DISCOVERY AND DEVELOPMENT OF NOVEL DRUG MOLECULES

6.1.2 RISE IN CHRONIC DISEASES

6.1.3 INITIATIVES FOR RESEARCH ON RARE DISEASES AND ORPHAN DRUGS

6.1.4 GROWTH IN BIOLOGICS

6.1.5 COLLABORATIONS AMONG RESEARCHERS AND PHARMACEUTICAL INDUSTRIES

6.2 RESTRAINTS

6.2.1 RISE IN COST OF FORMULATED DRUG

6.2.2 TECHNICAL RISKS IN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY

6.2.3 BIOETHICAL ISSUES IN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY

6.3 OPPORTUNITIES

6.3.1 ADVANCEMENTS IN BIOCHEMICAL, TRANSLATIONAL, AND MOLECULAR STUDIES

6.3.2 RISE IN HEALTHCARE EXPENDITURE

6.3.3 USE OF ARTIFICIAL INTELLIGENCE IN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY

6.4 CHALLENGES

6.4.1 BIOLOGICS NEED SPECIALIST TESTING SERVICES

6.4.2 STRINGENT REGULATIONS

7 IMPACT OF COVID-19 ON EUROPE MEDICINAL CHEMISTRY IN DRUG DISCOVERY MARKET

7.1 IMPACT ON PRICE

7.2 IMPACT ON DEMAND

7.3 IMPACT ON SUPPLY CHAIN

7.4 STRATEGIC DECISIONS BY MANUFACTURERS

7.5 CONCLUSION

8 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS

8.1 OVERVIEW

8.2 TARGET SELECTION

8.3 TARGET VALIDATION

8.4 HIT-TO-LEAD IDENTIFICATION

8.5 LEAD OPTIMIZATION

8.6 CANDIDATE VALIDATION

9 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN

9.1 OVERVIEW

9.2 FRAGMENT-BASED VARIATION

9.3 STRUCTURE BASED DRUG DESIGN

9.4 DIVERSITY ORIENTED SYNTHESIS

9.5 CHEMOGENOMICS

9.6 NATURAL PRODUCTS

9.7 OTHERS

10 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE

10.1 OVERVIEW

10.2 SMALL MOLECULES

10.3 BIOLOGICS

11 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA

11.1 OVERVIEW

11.2 ONCOLOGY

11.3 NEUROLOGY

11.4 INFECTIOUS AND IMMUNE SYSTEM DISEASES

11.5 CARDIOVASCULAR DISEASES

11.6 DIGESTIVE SYSTEM DISEASES

11.7 OTHERS

12 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER

12.1 OVERVIEW

12.2 CONTRACT RESEARCH ORGANIZATION

12.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES

12.4 ACADEMIC AND RESEARCH INSTITUTES

12.5 OTHERS

13 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY COUNTRY

13.1 EUROPE

13.1.1 GERMANY

13.1.2 FRANCE

13.1.3 U.K.

13.1.4 ITALY

13.1.5 SPAIN

13.1.6 NETHERLANDS

13.1.7 RUSSIA

13.1.8 SWITZERLAND

13.1.9 BELGIUM

13.1.10 TURKEY

13.1.11 AUSTRIA

13.1.12 NORWAY

13.1.13 HUNGARY

13.1.14 LITHUANIA

13.1.15 IRELAND

13.1.16 POLAND

13.1.17 REST OF EUROPE

14 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: EUROPE

15 SWOT ANALYSIS

16 COMPANY PROFILE

16.1 EUROFINS SCIENTIFIC

16.1.1 COMPANY SNAPSHOT

16.1.2 REVENUE ANALYSIS

16.1.3 COMPANY SHARE ANALYSIS

16.1.4 SERVICE PORTFOLIO

16.1.5 RECENT DEVELOPMENT

16.2 LABCORP DRUG DEVELOPMENT

16.2.1 COMPANY SNAPSHOT

16.2.2 REVENUE ANALYSIS

16.2.3 COMPANY SHARE ANALYSIS

16.2.4 SERVICE PORTFOLIO

16.2.5 RECENT DEVELOPMENT

16.3 CHARLES RIVER

16.3.1 COMPANY SNAPSHOT

16.3.2 REVENUE ANALYSIS

16.3.3 COMPANY SHARE ANALYSIS

16.3.4 SERVICE PORTFOLIO

16.3.5 RECENT DEVELOPMENTS

16.4 WUXI APPTEC

16.4.1 COMPANY SNAPSHOT

16.4.2 REVENUE ANALYSIS

16.4.3 COMPANY SHARE ANALYSIS

16.4.4 SERVICE PORTFOLIO

16.4.5 RECENT DEVELOPMENTS

16.5 EVOTEC SE

16.5.1 COMPANY SNAPSHOT

16.5.2 REVENUE ANALYSIS

16.5.3 COMPANY SHARE ANALYSIS

16.5.4 SERVICE PORTFOLIO

16.5.5 RECENT DEVELOPMENTS

16.6 PIRAMAL PHARMA SOLUTIONS

16.6.1 COMPANY SNAPSHOT

16.6.2 SERVICE PORTFOLIO

16.6.3 RECENT DEVELOPMENTS

16.7 THERMO FISHER SCIENTIFIC INC.

16.7.1 COMPANY SNAPSHOT

16.7.2 REVENUE ANALYSIS

16.7.3 SERVICE PORTFOLIO

16.7.4 RECENT DEVELOPMENT

16.7.4.1 ACQUISITION

16.8 AURIGENE PHARMACEUTICAL SERVICES (A SUBSIDIARY OF DR. REDDY'S LABORATORIES)

16.8.1 COMPANY SNAPSHOT

16.8.2 REVENUE ANALYSIS

16.8.3 SERVICE PORTFOLIO

16.8.4 RECENT DEVELOPMENT

16.9 AURELIA BIOSCIENCES

16.9.1 COMPANY SNAPSHOT

16.9.2 SERVICE PORTFOLIO

16.9.3 RECENT DEVELOPMENTS

16.1 BIOBLOCKS INC

16.10.1 COMPANY SNAPSHOT

16.10.2 SERVICE PORTFOLIO

16.10.3 RECENT DEVELOPMENT

16.11 CERTARA INC

16.11.1 COMPANY SNAPSHOT

16.11.2 REVENUE ANALYSIS

16.11.3 SERVICE PORTFOLIO

16.11.4 RECENT DEVELOPMENTS

16.12 DOMAINEX

16.12.1 COMPANY SNAPSHOT

16.12.2 SERVICE PORTFOLIO

16.12.3 RECENT DEVELOPMENT

16.13 GENSCRIPT BIOTECH

16.13.1 COMPANY SNAPSHOT

16.13.2 REVENUE ANALYSIS

16.13.3 SERVICE PORTFOLIO

16.13.4 RECENT DEVELOPMENT

16.14 PFIZER INC.

16.14.1 COMPANY SNAPSHOT

16.14.2 REVENUE ANALYSIS

16.14.3 SERVICE PORTFOLIO

16.14.4 RECENT DEVELOPMENTS

16.15 SELVITA

16.15.1 COMPANY SNAPSHOT

16.15.2 REVENUE ANALYSIS

16.15.3 SERVICE PORTFOLIO

16.15.4 RECENT DEVELOPMENTS

16.15.4.1 ACQUISITION

16.16 SPECTRIS PLC

16.16.1 COMPANY SNAPSHOT

16.16.2 REVENUE ANALYSIS

16.16.3 SERVICE PORTFOLIO

16.16.4 RECENT DEVELOPMENT

16.17 SYGNATURE DISCOVERY

16.17.1 COMPANY SNAPSHOT

16.17.2 SERVICE PORTFOLIO

16.17.3 RECENT DEVELOPMENTS

16.18 TAROS CHEMICAL GMBH

16.18.1 COMPANY SNAPSHOT

16.18.2 SERVICE PORTFOLIO

16.18.3 RECENT DEVELOPMENT

17 QUESTIONNAIRE

18 RELATED REPORTS

표 목록

TABLE 1 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)

TABLE 2 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)

TABLE 3 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)

TABLE 4 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)

TABLE 5 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 6 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 7 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)

TABLE 8 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)

TABLE 9 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)

TABLE 10 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)

TABLE 11 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 12 GERMANY MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)

TABLE 13 GERMANY MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)

TABLE 14 GERMANY MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)

TABLE 15 GERMANY MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)

TABLE 16 GERMANY MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 17 FRANCE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)

TABLE 18 FRANCE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)

TABLE 19 FRANCE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)

TABLE 20 FRANCE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)

TABLE 21 FRANCE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 22 U.K. MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)

TABLE 23 U.K. MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)

TABLE 24 U.K. MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)

TABLE 25 U.K. MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)

TABLE 26 U.K. MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 27 ITALY MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)

TABLE 28 ITALY MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)

TABLE 29 ITALY MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)

TABLE 30 ITALY MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)

TABLE 31 ITALY MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 32 SPAIN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)

TABLE 33 SPAIN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)

TABLE 34 SPAIN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)

TABLE 35 SPAIN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)

TABLE 36 SPAIN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 37 NETHERLANDS MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)

TABLE 38 NETHERLANDS MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)

TABLE 39 NETHERLANDS MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)

TABLE 40 NETHERLANDS MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)

TABLE 41 NETHERLANDS MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 42 RUSSIA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)

TABLE 43 RUSSIA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)

TABLE 44 RUSSIA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)

TABLE 45 RUSSIA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)

TABLE 46 RUSSIA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 47 SWITZERLAND MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)

TABLE 48 SWITZERLAND MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)

TABLE 49 SWITZERLAND MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)

TABLE 50 SWITZERLAND MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)

TABLE 51 SWITZERLAND MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 52 BELGIUM MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)

TABLE 53 BELGIUM MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)

TABLE 54 BELGIUM MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)

TABLE 55 BELGIUM MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)

TABLE 56 BELGIUM MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 57 TURKEY MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)

TABLE 58 TURKEY MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)

TABLE 59 TURKEY MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)

TABLE 60 TURKEY MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)

TABLE 61 TURKEY MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 62 AUSTRIA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)

TABLE 63 AUSTRIA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)

TABLE 64 AUSTRIA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)

TABLE 65 AUSTRIA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)

TABLE 66 AUSTRIA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 67 NORWAY MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)

TABLE 68 NORWAY MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)

TABLE 69 NORWAY MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)

TABLE 70 NORWAY MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)

TABLE 71 NORWAY MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 72 HUNGARY MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)

TABLE 73 HUNGARY MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)

TABLE 74 HUNGARY MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)

TABLE 75 HUNGARY MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)

TABLE 76 HUNGARY MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 77 LITHUANIA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)

TABLE 78 LITHUANIA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)

TABLE 79 LITHUANIA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)

TABLE 80 LITHUANIA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)

TABLE 81 LITHUANIA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 82 IRELAND MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)

TABLE 83 IRELAND MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)

TABLE 84 IRELAND MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)

TABLE 85 IRELAND MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)

TABLE 86 IRELAND MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 87 POLAND MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)

TABLE 88 POLAND MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)

TABLE 89 POLAND MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)

TABLE 90 POLAND MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)

TABLE 91 POLAND MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 92 REST OF EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)

그림 목록

FIGURE 1 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: SEGMENTATION

FIGURE 2 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: DROC ANALYSIS

FIGURE 4 MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: EUROPE VS REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: END USER COVERAGE GRID

FIGURE 8 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: SEGMENTATION

FIGURE 11 GROWTH IN BIOLOGICS DISCOVERY AND COLLABORATION AMONG RESEARCHERS AND PHARMACEUTICAL INDUSTRY IS EXPECTED TO DRIVE THE EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 12 PROCESS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET IN 2022 & 2029

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET

FIGURE 14 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY PROCESS, 2021

FIGURE 15 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY PROCESS, 2020-2029 (USD MILLION)

FIGURE 16 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY PROCESS, CAGR (2022-2029)

FIGURE 17 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY PROCESS, LIFELINE CURVE

FIGURE 18 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DESIGN, 2021

FIGURE 19 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DESIGN, 2020-2029 (USD MILLION)

FIGURE 20 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DESIGN, CAGR (2022-2029)

FIGURE 21 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DESIGN, LIFELINE CURVE

FIGURE 22 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DRUG TYPE, 2021

FIGURE 23 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DRUG TYPE, 2020-2029 (USD MILLION)

FIGURE 24 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DRUG TYPE, CAGR (2022-2029)

FIGURE 25 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DRUG TYPE, LIFELINE CURVE

FIGURE 26 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY THERAPEUTIC AREA, 2021

FIGURE 27 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)

FIGURE 28 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY THERAPEUTIC AREA, CAGR (2022-2029)

FIGURE 29 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY THERAPEUTIC AREA, LIFELINE CURVE

FIGURE 30 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY END USER, 2021

FIGURE 31 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY END USER, 2020-2029 (USD MILLION)

FIGURE 32 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY END USER, CAGR (2022-2029)

FIGURE 33 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY END USER, LIFELINE CURVE

FIGURE 34 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: SNAPSHOT (2021)

FIGURE 35 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY COUNTRY (2021)

FIGURE 36 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY COUNTRY (2022 & 2029)

FIGURE 37 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY COUNTRY (2021 & 2029)

FIGURE 38 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY PROCESS (2022-2029)

FIGURE 39 EUROPE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: COMPANY SHARE 2021 (%)

자세한 정보 보기 Right Arrow

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.

DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.

사용자 정의 가능

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.